These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 18488876)

  • 1. Testosterone for the aging male; current evidence and recommended practice.
    Stanworth RD; Jones TH
    Clin Interv Aging; 2008; 3(1):25-44. PubMed ID: 18488876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
    Yassin DJ; Doros G; Hammerer PG; Yassin AA
    J Sex Med; 2014 Jun; 11(6):1567-76. PubMed ID: 24712761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism.
    Permpongkosol S; Khupulsup K; Leelaphiwat S; Pavavattananusorn S; Thongpradit S; Petchthong T
    J Sex Med; 2016 Aug; 13(8):1199-211. PubMed ID: 27436076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Update of the 2010 Endocrine Society Clinical Practice Guidelines for Male Hypogonadism: A Systematic Analysis.
    Seftel AD; Kathrins M; Niederberger C
    Mayo Clin Proc; 2015 Aug; 90(8):1104-15. PubMed ID: 26205546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.
    Behre HM; Heinemann L; Morales A; Pexman-Fieth C
    Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone treatment in the aging male: myth or reality?
    Nigro N; Christ-Crain M
    Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects.
    Schubert M; Jockenhövel F
    J Endocrinol Invest; 2005; 28(3 Suppl):23-7. PubMed ID: 16042356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men.
    Saad F; Yassin A; Haider A; Doros G; Gooren L
    Korean J Urol; 2015 Apr; 56(4):310-7. PubMed ID: 25874045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current topics in testosterone replacement of hypogonadal men.
    Nieschlag E
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):77-90. PubMed ID: 25617174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMAS position statement: Testosterone replacement therapy in the aging male‏.
    Dimopoulou C; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; Rees M; van der Schouw YT; Senturk LM; Simonsini T; Stevenson JC; Stute P; Goulis DG
    Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Testosterone replacement treatment in older people with and without co-morbidities].
    Zitzmann M
    Internist (Berl); 2020 Jun; 61(6):549-557. PubMed ID: 32377774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone deficiency in men with Type 2 diabetes: pathophysiology and treatment.
    Gianatti EJ; Grossmann M
    Diabet Med; 2020 Feb; 37(2):174-186. PubMed ID: 31006133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints.
    Permpongkosol S; Tantirangsee N; Ratana-olarn K
    J Sex Med; 2010 Nov; 7(11):3765-74. PubMed ID: 20807330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
    Mäkinen JI; Huhtaniemi I
    Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrinology Update: Testicular Hypogonadism.
    Heidelbaugh JJ
    FP Essent; 2016 Dec; 451():31-41. PubMed ID: 27936533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone therapy in erectile dysfunction and hypogonadism.
    Shabsigh R
    J Sex Med; 2005 Nov; 2(6):785-92. PubMed ID: 16422803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism.
    Tirabassi G; Corona G; Biagioli A; Buldreghini E; delli Muti N; Maggi M; Balercia G
    J Sex Med; 2015 Feb; 12(2):381-8. PubMed ID: 25443437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome.
    Giltay EJ; Tishova YA; Mskhalaya GJ; Gooren LJ; Saad F; Kalinchenko SY
    J Sex Med; 2010 Jul; 7(7):2572-82. PubMed ID: 20524974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.